Balkrishan Kalra - Dec 13, 2024 Form 4 Insider Report for Genpact LTD (G)

Signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for Balkrishan Kalra
Stock symbol
G
Transactions as of
Dec 13, 2024
Transactions value $
-$230,520
Form type
4
Date filed
12/17/2024, 04:01 PM
Previous filing
Nov 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction G Common Shares Options Exercise $376K +13.6K +5.09% $27.65 281K Dec 13, 2024 Direct F1
transaction G Common Shares Sale -$607K -13.6K -4.84% $44.60 267K Dec 13, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction G Employee Stock Option (Right to Buy) Options Exercise $0 -13.6K -19.43% $0.00 56.4K Dec 13, 2024 Common Shares 13.6K $27.65 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024.
F2 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.47 to $44.78. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The option vested 50% on January 10, 2019 and the remainder on January 10, 2021.